Table 1.

Characteristics of Patients Receiving IVIG

PatientAge/SexDiagnosisImmune StatusPS (ECOG) at IVIGOther TreatmentsTransfusions
Before IVIGAfter IVIG
AA 58/M CLL ID CHOP/splenectomy CHOP Yes 
BF 47/M CLL ID CHOP/fludarabine Steroid No 
FF 28/F SAA ID Steroid/cyclosporin Steroid/cyclosporin Yes 
FA 64/M LG-NHL ID CHOP No 
LM 64/F LG-NHL ID Yes 
LF 63/M CVID ID No 
VE 77/M CLL ID Steroid/chlorambucil Steroid/chlorambucil Yes 
BI 64/F ITP IC Steroid No 
BFA 46/F ITP IC Steroid Steroid/splenectomy Yes 
EG 48/F ITP IC Steroid Steroid No 
GA 51/F ITP IC Steroid Steroid No 
LT 71/F ITP IC Steroid Splenectomy Yes 
SG 30/F ITP IC Steroid Splenectomy No 
PatientAge/SexDiagnosisImmune StatusPS (ECOG) at IVIGOther TreatmentsTransfusions
Before IVIGAfter IVIG
AA 58/M CLL ID CHOP/splenectomy CHOP Yes 
BF 47/M CLL ID CHOP/fludarabine Steroid No 
FF 28/F SAA ID Steroid/cyclosporin Steroid/cyclosporin Yes 
FA 64/M LG-NHL ID CHOP No 
LM 64/F LG-NHL ID Yes 
LF 63/M CVID ID No 
VE 77/M CLL ID Steroid/chlorambucil Steroid/chlorambucil Yes 
BI 64/F ITP IC Steroid No 
BFA 46/F ITP IC Steroid Steroid/splenectomy Yes 
EG 48/F ITP IC Steroid Steroid No 
GA 51/F ITP IC Steroid Steroid No 
LT 71/F ITP IC Steroid Splenectomy Yes 
SG 30/F ITP IC Steroid Splenectomy No 

Abbreviations: PS, performance status; CLL, chronic lymphatic leukemia; LG-NHL, low-grade non-Hodgkin's lymphoma; SAA, severe aplastic anemia; CVID, common variable immunodeficiency; ITP, idiopathic thrombocytopenic purpura; ID, immunodeficient; IC, immunocompetent.

Close Modal

or Create an Account

Close Modal
Close Modal